Brief: Kuros Biosciences AG: 9M Update On Commercial Activities
Oct 12 (Reuters) - Kuros Biosciences AG KURN.S :
* DIRECT MAGNETOS SALES GREW TO CHF 20.4 MILLION IN THE
FIRST NINE
MONTHS OF 2023, CLIMBING FROM CHF 8.1 MILLION IN THE SAME PERIOD
IN 2022
* ANNOUNCES CHANGES AND A TRANSITION IN RESPONSIBILITIES
WITHIN
EXECUTIVE MANAGEMENT
Further company coverage: KURN.S
(Reporting by Berlin Newsroom)
((berlin.newsroom@thomsonreuters.com;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million